Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis.
about
Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysisVarenicline as a Cause of Suicidal OutcomesE-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: secondary analysis of data from the ASCEND trial.Targeting the schizophrenia genome: a fast track strategy from GWAS to clinic.Pharmacological treatment of schizophrenia with comorbid substance use disorder.Update on Smoking Cessation: E-Cigarettes, Emerging Tobacco Products Trends, and New Technology-Based Interventions.Varenicline for smoking cessation and reduction in people with severe mental illnesses: systematic review and meta-analysis.Predictors of smoking reduction outcomes in a sample of 287 patients with schizophrenia spectrum disorders.T. Kishi and N. Iwata: Varenicline for smoking cessation in people with schizophrenia: systematic review meta-analysis.Smoking Cessation and Electronic Cigarettes in Community Mental Health Centers: Patient and Provider Perspectives.Nicotine dependence is associated with depression and childhood trauma in smokers with schizophrenia: results from the FACE-SZ dataset.A comparison of neuropsychiatric adverse events during early treatment with varenicline or a nicotine patch.Answering the question or questioning the answer?The effectiveness and safety of combining varenicline with nicotine e-cigarettes for smoking cessation in people with mental illnesses and addictions: study protocol for a randomised-controlled trial.Efficacy and Safety of Varenicline for Smoking Cessation in Schizophrenia: A Meta-Analysis
P2860
Q28083649-7704786F-BF47-4B27-A57F-6F81EAECE4E2Q28255130-C80079C4-9EE0-4256-8436-A62973481B02Q34468904-307D099F-DEED-493D-BC3E-5D907A82B2ADQ35802177-D9CA9176-7407-4C16-9719-88C82357984CQ38658672-0392C159-E6C4-40E9-9787-B70BB5829C49Q38796897-FF518CD2-F483-4244-9FFC-A33255192871Q38797685-BC58CFAA-1ADF-4DB9-B272-19765D5F939FQ41449133-FB89151A-2E0F-41E4-8C0B-191053F165F2Q42394613-B59D5295-21CE-4F4D-9B00-7EC4CBEED638Q47864763-055A5CC2-1FF6-4C6B-8988-BE87B4A8C521Q47921866-BB732B0B-C3A0-461D-A82F-AAC5C91128B8Q48065103-76FEC366-67A4-4D43-AE0A-8912AF0799C2Q48367776-117361EF-21B1-445A-AF54-49B6646805E8Q53825728-0788D8DD-9F21-42D4-81E1-B198AB15B803Q57073141-93A22761-6502-4E69-92C3-D3660A338B96
P2860
Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Varenicline for smoking cessat ...... atic review and meta-analysis.
@ast
Varenicline for smoking cessat ...... atic review and meta-analysis.
@en
type
label
Varenicline for smoking cessat ...... atic review and meta-analysis.
@ast
Varenicline for smoking cessat ...... atic review and meta-analysis.
@en
prefLabel
Varenicline for smoking cessat ...... atic review and meta-analysis.
@ast
Varenicline for smoking cessat ...... atic review and meta-analysis.
@en
P2860
P1476
Varenicline for smoking cessat ...... matic review and meta-analysis
@en
P2093
Taro Kishi
P2860
P2888
P304
P356
10.1007/S00406-014-0551-3
P50
P577
2014-10-05T00:00:00Z